BioSpace News Archive

Business

CONMED Corporation to Announce Second Quarter 2021 Financial Results on July 28, 2021

CONMED Corporation announced that it will report financial results for the second quarter 2021 after the market close on Wednesday, July 28, 2021.

July 1, 2021
·
2 min read
Biotech Beach

Denovo Biopharma In-Licenses Late-Stage Alzheimer’s Disease Asset from Lundbeck

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed global rights for idalopirdine from H. Lundbeck A/S, including all rights to develop, manufacture and commercialize idalopirdine for all indications.

July 1, 2021
·
3 min read
Biotech Beach

Ensysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021

Ensysce Biosciences, Inc. announced that the Company will begin trading its common stock under the ticker symbol “ENSC” on The Nasdaq Capital Market and warrants under the ticker symbol “ENSCW” on the OTC Market on July 2, 2021.

July 1, 2021
·
2 min read
Genetown

Novanta to Present at the 21st Annual CJS Securities New Ideas Summer (Virtual) Conference on Tuesday, July 13, 2021

Novanta Inc. (Nasdaq:NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the 21st Annual CJS Securities New Ideas Summer Conference

July 1, 2021
·
1 min read
Blood Culture Tests Market Size To Reach USD 8.2 Billion By 2028

High demand for rapid diagnostic tests, increasing investments for developing enhanced blood culture tests, and rising prevalence of various infectious diseases are key factors fueling global market growth.

July 1, 2021
·
5 min read
Kidney Function Test Market to Reach USD 1.2 Billion by 2028 – Reports and Data

Rising incidence of acute and chronic kidney diseases, high occurrence of hypertension and diabetes, and increasing investments in research and development activities are key factors boosting global market growth.

July 1, 2021
·
5 min read
Synthetic Biology Market To Reach USD 24.54 Billion By 2028 – Reports and Data

Increasing R&D investments in drug discovery and reduced cost of DNA sequencing and synthesizing are the major factors influencing industry growth.

July 1, 2021
·
5 min read
Point of Care (PoC) Diagnostics Market Size to Reach USD 60.67 Billion in 2028 – Reports and Data

Growing geriatric population worldwide and surging prevalence of diabetes and cardiovascular diseases are projected to drive market growth.

July 1, 2021
·
6 min read
Business

Oncternal Therapeutics Appoints Pablo Urbaneja as Sr. Vice President, Corporate Development

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Pablo Urbaneja as Senior Vice President, Corporate Development.

July 1, 2021
·
3 min read
Biotech Bay

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 01, 2021

Cytokinetics, Incorporated announced that on June 30, 2021 it granted stock options to purchase an aggregate of 90,000 shares of common stock to twelve new employees whose employment commenced in June 2021 as a material inducement to their employment.

July 1, 2021
·
3 min read